View this email online

Stay up-to-date with the latest O&T News in Europe

Read EFORT's official Newsletter with a round up of all EFORT activities

Issue I - January 2024

EFORT Open Reviews

High-quality instructional peer-reviewed articles

across the whole field of Orthopaedics and Traumatology


VOL.8, N° 12, DECEMBER 2023

📄 Return to driving post upper

or lower extremity

orthopaedic surgical procedures:

a scoping review of current published literature

Mehnoor Khaliq, Vasileios P Giannoudis, 

Jeya Palan, Hemant G Pandit,

and Bernard H van Duren

📄 Does lower-limb osteoarthritis alter motor cortex descending drive and voluntary activation? A systematic review and meta-analysis

Myles C Murphy, 

Christopher Latella, Ebonie K Rio, 

Janet L Taylor, Stephanie Martino, 

Colin Sylvester, William Hale,

and Andrea B Mosler


📄 Current indications

for denosumab in benign bone tumours

Antal Imre, 

Sápi Zoltán,

and Szendrői Miklós

EFORT e-learning

Save the date for the upcoming EFORT Webinar

On Monday 29 January 2024 at 19:00 CET, the EFORT Webinar on Limits of The Masquelet Technique in Segmental Bone Defects will focus on the management of “critical size” bone defects. This event will be chaired by Thierry Bégué, France.

The objectives of this webinar are:

  • To identify what is a “critical size” bone defects;
  • To assess bone defect area for evaluation of bone and soft tissue;
  • To learn about the healing process and pitfalls with the different techniques of bone reconstruction.

This Webinar is organised by EFORT independent of any commercial educational support.


The IODA Charter

A commitment to work at improving diversity, equity and inclusion in O& T

IODA, the International Orthopaedic Diversity Alliance announces increased interest from surgical societies, industry and academic publishers for promoting diversity, equity and inclusion in the speciality by becoming signatories to its Charter.

Others wishing to engage can go to the Charter webpage.

Since the launch of the IODA Charter in 2022, twenty organisations worldwide have signed the Charter – half of which are European.

This engagement is encouraging, but what does it mean to sign the IODA Charter? It is a public commitment to work at improving diversity, equity and inclusion (DEI) in the specialty; and from feedback IODA has received thus far, an incentive to carry out the important work required to achieve these great objectives.

The IODA Charter highlights action points that can assist your organisation or society focus and initiate objectives to drive culture change based on the identified barriers. These action points can be implemented into local strategic plans and policies —see road map below. IODA is excited to see outlined DEI metrics improve over time from this important work all around the world.


IT tools for regulatory science

If you missed the CORE-MD Project webinar on IT tools for regulatory science: aggregating available data for assisting Expert Panels and improving post-market surveillance it is now available from the CORE-MD Youtube channel.

This webinar aimed to:

  • To discover the activities performed during the CORE-MD project in support to automated data aggregation of safety notices for post-market surveillance.
  • To understand EMA Expert Panel’s roles in post-market surveillance and vigilance.
  • To receive regulator’s perspective on the use of real-world evidence.

CORE-MD is a European Union Horizon 2020 project. It reviews methods for evaluating high-risk medical devices in order to translate expert evidence into advice for EU regulators and to recommend an appropriate balance between innovation, safety , and clinical effectiveness.


EFORT Resources

A quick access to prime educational material



LinkedInFacebookInstagramTwitterYouTubeEmail Address